THE REFRACTORY OVERACTIVE BLADDER: SACRAL NEUROMODULATION VS. BOTULINUM TOXIN ASSESSMENT (ROSETTA)

被引：0
|
作者：
Amundsen, C. [1 ]
Richter, H. [2 ]
Menefee, S. [3 ]
Komesu, Y. [4 ]
Arya, L. [5 ]
Gregory, W. T. [6 ]
Myers, D. [7 ]
Zyczynski, H. [8 ]
Vasavada, S. [9 ]
Nolen, T. [10 ]
Wallace, D. [10 ]
Meikle, S. [11 ]
机构：
[1] Duke Univ, Durham, NC 27706 USA
[2] Univ Alabama, Tuscaloosa, AL 35487 USA
[3] Kaiser Permanente San Diego, San Diego, CA USA
[4] Univ New Mexico, Albuquerque, NM 87131 USA
[5] Univ Penn, Philadelphia, PA 19104 USA
[6] Oregon Hlth & Sci Univ, Portland, OR USA
[7] Brown Univ, Providence, RI 02912 USA
[8] Univ Pittsburgh, Pittsburgh, PA 15260 USA
[9] Cleveland Clin, Cleveland, OH 44106 USA
[10] RTI Int, Res Triangle Pk, NC USA
[11] NICHD, Bethesda, MD USA
来源：
NEUROUROLOGY AND URODYNAMICS | 2016年 / 35卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
1
引用
收藏
页码：S23 / S24
页数：2
相关论文
共 50 条
  • [1] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA trial
    Amundsen, Cindy L.
    Richter, Holly E.
    Menefee, Shawn
    Vasavada, Sandip
    Rahn, David D.
    Kenton, Kim
    Harvie, Heidi S.
    Wallace, Dennis
    Meikle, Susie
    CONTEMPORARY CLINICAL TRIALS, 2014, 37 (02) : 272 - 283
  • [2] The Refractory Overactive Bladder: Sacral NEuromodulation vs. BoTulinum Toxin Assessment: ROSETTA Trial
    Hall, Evelyn
    OBSTETRICS AND GYNECOLOGY, 2017, 129 (01): : 201 - 201
  • [3] Sacral neuromodulation and intravesical botulinum toxin for refractory overactive bladder
    Kantartzis, Kelly
    Shepherd, Jonathan
    CURRENT OPINION IN OBSTETRICS & GYNECOLOGY, 2012, 24 (05) : 331 - 336
  • [4] Cost Effectiveness of Sacral Neuromodulation and Botulinum Toxin A in Managing Refractory Overactive Bladder
    Hadidi, S.
    Atiiga, P. A.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 258 - 258
  • [5] Sacral neuromodulation and botulinum toxin for overactive neurogenic bladder in children
    Aubert, D.
    Galli, G.
    Ramella, B.
    Moro-Enemuwe, A.
    Fotso-Kamden, A.
    PELVI-PERINEOLOGIE, 2007, 2 (03): : 244 - 248
  • [6] LONG TERM COST EFFECTIVENESS OF BOTULINUM TOXIN A AND SACRAL NEUROMODULATION FOR PATIENTS WITH REFRACTORY OVERACTIVE BLADDER
    Harry, D.
    Roberts, S.
    Parkin, D.
    Malde, S.
    Al-Kaisy, A.
    Sahai, A.
    NEUROUROLOGY AND URODYNAMICS, 2015, 34 : S240 - S240
  • [7] Sacral Neuromodulation for refractory overactive Bladder
    van Ophoven, Arndt
    UROLOGE, 2018, 57 (11): : 1375 - 1388
  • [8] Current Information on Sacral Neuromodulation and Botulinum Toxin Treatment for Refractory Idiopathic Overactive Bladder Syndrome: A Review
    Leong, Randall K.
    De Wachter, Stefan G. G.
    van Kerrebroeck, Philip E. V.
    UROLOGIA INTERNATIONALIS, 2010, 84 (03) : 245 - 253
  • [9] COST-EFFECTIVENESS OF SACRAL NEUROMODULATION AND BOTULINUM TOXIN-A FOR PATIENTS WITH REFRACTORY IDIOPATHIC OVERACTIVE BLADDER
    Clemens, J. Quentin
    Anger, Jennifer T.
    Ganz, Michael L.
    Denevich, Svetlana
    Shah, Dhvani
    Carlson, Angeline M.
    Wittek, Michael R.
    Pashos, Chris L.
    NEUROUROLOGY AND URODYNAMICS, 2012, 31 (02) : 223 - 223
  • [10] A comparative study between sacral neuromodulation and intravesical botulinum toxin injection for patients with refractory overactive bladder
    Al-Azzawi, Issam S.
    Al-Hindawi, Haider T.
    ARAB JOURNAL OF UROLOGY, 2020, 18 (02) : 88 - 93
12345